| Income Statement |
| Operating Expenses | 12.26M |
|
| Research and Development Expense | 9.12M |
| Selling, General and Administrative Expense | 3.65M |
| Operating Income | -12.26M |
| Net Income | -12.41M |
| Net Income Common Stock | -12.41M |
| Net Income Common Stock (USD) | -12.41M |
| Consolidated Income | -12.41M |
| Earnings per Basic Share | -0.17 |
| Earnings per Basic Share (USD) | -0.17 |
| Earnings per Diluted Share | -0.17 |
| Earning Before Interest & Taxes (EBIT) | -12.41M |
| Earning Before Interest & Taxes (USD) | -12.41M |
| Weighted Average Shares | 72.30M |
| Weighted Average Shares Diluted | 72.30M |
| Balance Sheet |
| Cash and Equivalents | 45.06M |
| Cash and Equivalents (USD) | 45.06M |
| Current Assets | 46.32M |
| Property, Plant & Equipment Net | 67.00K |
| Total Assets | 46.39M |
| Debt Current | 1.24M |
| Total Debt | 1.24M |
| Current Liabilities | 9.29M |
| Total Liabilities | 27.67M |
| Accumulated Retained Earnings (Deficit) | -461.46M |
| Shareholders Equity | 18.72M |
| Shareholders Equity (USD) | 18.72M |
| Assets Non-Current | 67.00K |
| Total Debt (USD) | 1.24M |
| Liabilities Non-Current | 18.37M |
| Trade and Non-Trade Payables | 4.61M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 46.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.12M |
| Capital Expenditure | 550.00K |
| Net Cash Flow from Investing | 550.00K |
| Net Cash Flow from Operations | -11.67M |
| Share Based Compensation | 1.58M |